Advances in protein kinase B signalling: AKTion on multiple fronts

Trends in Biochemical Sciences

Volumn 29, Issue 5, 2004, Pages 233-242

  Brazil, Derek P ^a,b   Yang, Zhong Zhou ^c   Hemmings, Brian A ^c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Dublin Molecular Medicine Centre   (Ireland)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CYCLIN B; CYCLIN D; CYCLIN E; ECDYSTEROID; GLUCOSE; HUNTINGTIN; INSULIN; MESSENGER RNA; PROTEIN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P27; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 10; CYTOPLASM; DIABETES MELLITUS; DNA REPAIR; DROSOPHILA; FLOW CYTOMETRY; GENE DELETION; GENE OVEREXPRESSION; GENE THERAPY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEART INFARCTION; HIBERNATION; HUNTINGTON CHOREA; INSULIN RESISTANCE; METAPHASE; MOSQUITO; MOTONEURON; NERVE DEGENERATION; NEUROBIOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OVARY; PATHOGENESIS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SCIURIDAE; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION; T CELL LYMPHOMA; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL CYCLE; ENZYME ACTIVATION; GENE EXPRESSION; ISOENZYMES; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NEURODEGENERATIVE DISEASES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

AEDES AEGYPTI; MARMOTA; MARMOTA FLAVIVENTRIS; MUS; MUS MUSCULUS; MUSCULUS; SCIURIDAE;

EID: 2342565881     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.03.006     Document Type: Review

References (78)

1. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:2001;657-664
2. Hill M.M., Hemmings B.A. Inhibition of protein kinase B/Akt: implications for cancer therapy. Pharmacol. Ther. 93:2002;243-251
3. Scheid M.P., Woodgett J.R. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546:2003;108-112
4. Whiteman E.L., et al. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13:2002;444-451
5. Datta S.R., et al. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927
6. Datta S.R., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241
7. Franke F.T., et al. PI3K: downstream AKTion blocks apoptosis. Cell. 88:1997;435-437
8. Kip1. J. Biol. Chem. 275:2000;21960-21968
9. kip1. Nature. 404:2000;782-787
10. Liang J., et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:2002;1153-1160
11. Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8:2002;1145-1152
12. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:2002;1136-1144
13. Montagnoli A., et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1999;1181-1189
14. Skp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9:1999;661-664
15. Kip1. EMBO J. 16:1997;5334-5344
16. Tsihlias J., et al. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu. Rev. Med. 50:1999;401-423
17. Fujita E., et al. Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem. Biophys. Res. Commun. 264:1999;550-555
18. Kandel E.S., et al. Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage. Mol. Cell. Biol. 22:2002;7831-7841
19. Shtivelman E., et al. A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr. Biol. 12:2002;919-924
20. Okumura E., et al. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat. Cell Biol. 4:2002;111-116
21. Tran H., et al. DNA repair pathway stimulated by the Forkhead transcription factor FOXO3a through the Gadd45 protein. Science. 296:2002;530-534
22. Basu S., et al. Akt phosphorylates the yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell. 11:2003;11-23
23. Kim A.H., et al. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 35:2002;697-709
24. Figueroa C., et al. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J. Biol. Chem. 278:2003;47922-47927
25. Schwertfeger K.L., et al. Prolactin stimulates activation of c-Jun N-terminal kinase (JNK). Mol. Endocrinol. 14:2000;1592-1602
26. Wang Q., et al. Control of synaptic strength, a novel function of Akt. Neuron. 38:2003;915-928
27. Chen H.K., et al. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 113:2003;457-468
28. Humbert S., et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell. 2:2002;831-837
29. Saudou F., et al. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:1998;55-66
30. Kaspar B.K., et al. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 301:2003;839-842
31. Yang J., et al. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell. 9:2002;1227-1240
32. Yang J., et al. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol. 9:2002;940-944
33. Huang X., et al. Crystal structure of an inactive Akt2 kinase domain. Structure. 11:2003;21-30
34. Thomas C.C., et al. High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3, 4, 5)-trisphosphate. Curr. Biol. 12:2002;1256-1262
35. Xu J., et al. The role of Asp-462 in regulating Akt activity. J. Biol. Chem. 277:2002;35561-35566
36. Conus N.M., et al. Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase. J. Biol. Chem. 277:2002;38021-38028
37. Andjelkovic M., et al. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5699-5704
38. Martelli A.M., et al. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia. 17:2003;1794-1805
39. Chaudhary L.R., Hruska K.A. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J. Cell. Biochem. 89:2003;1-5
40. Chun K.-H., et al. Effects of degeulin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J. Natl. Cancer Inst. 95:2003;291-302
41. Meuillet E.J., et al. Specific inhibition of the Akt1 pleckstrin homology domain by D-3-deoxy-phosphatidyl-myo-inositol analogues. Mol. Cancer Ther. 2:2003;389-399
42. Turek T.C., et al. Development and validation of a competitive AKT serine/threonine kinase fluorescence polarization assay using a product-specific anti-phospho-serine antibody. Anal. Biochem. 299:2001;45-53
43. Tazzari P.L., et al. Flow cytometric detection of total and serine 473 phosphorylated Akt. J. Cell. Biochem. 86:2002;704-715
44. Sasaki K., et al. Fluorescent indicators for Akt/protein kinase B and dynamics of Akt activity visualized in living cells. J. Biol. Chem. 278:2003;30945-30951
45. Maira S.-M., et al. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science. 294:2001;374-380
46. Du K., et al. TRB3: A tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 300:2003;1574-1577
47. van den Heuvel A.P.J., et al. Binding of protein kinase B to the plakin family member periplakin. J. Cell Sci. 115:2002;3957-3966
48. Cenni V., et al. Targeting of the Akt/PKB kinase to the actin skeleton. Cell. Mol. Life Sci. 60:2003;2710-2720
49. Li L., et al. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol. Cell. Biol. 23:2003;9389-9404
50. Yang G., et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4:1998;1873-1880
51. Fukuda T., et al. CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt. J. Cell Biol. 160:2003;1001-1008
52. Leslie N.R., et al. Phosphoinositide-regulated kinases and phosphoinositide phosphatases. Chem. Rev. 101:2001;2365-2380
53. Delcommenne M., et al. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11211-11216
54. Persad S., et al. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 97:2000;3207-3212
55. Persad S., et al. Regulation of protein kinase B/Akt serine 473 phosphorylation by integrin-linked kinase. Critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 276:2001;27462-27469
56. Troussard A.A., et al. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J. Biol. Chem. 278:2003;22374-22378
57. Sakai T., et al. Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation. Genes Dev. 17:2003;926-940
58. Hill M.M., et al. Identification of a plasma membrane raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1. Curr. Biol. 12:2002;1251-1255
59. Hill M.M., et al. Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine- insensitive kinase. J. Biol. Chem. 276:2001;25643-25646
60. Matsui T., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:2002;22896-22901
61. Shioi T., et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22:2002;2799-2809
62. Condorelli G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;12333-12338
63. Malstrom S., et al. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc. Natl. Acad. Sci. U. S. A. 98:2001;14967-14972
64. Tuttle R.L., et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα Nat. Med. 7:2001;1133-1137
65. Bernal-Mizrachi E., et al. Islet β-cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest. 108:2001;1631-1638
66. Schwertfeger K.L., et al. Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J. Lipid Res. 44:2003;1100-1112
67. Majumder P.K., et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc. Natl. Acad. Sci. U. S. A. 100:2003;7841-7846
68. Mangi A.A., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9:2003;1195-1201
69. Katome T., et al. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J. Biol. Chem. 278:2003;28312-28323
70. Jiang Z.Y., et al. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. U. S. A. 100:2003;7569-7574
71. Bae S.S., et al. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278:2003;49530-49536
72. Cho H., et al. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276:2001;38349-38352
73. Chen W.S., et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene. Genes Dev. 15:2001;2203-2208
74. Yang Z.-Z., et al. Protein kinase Bα/Akt1 regulates placental development and fetal growth. J. Biol. Chem. 278:2003;32124-32131
75. Garofalo R.S., et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ J. Clin. Invest. 112:2003;197-208
76. Cho H., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science. 292:2001;1728-1731
77. Peng X.D., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17:2003;1352-1365
78. Sinha D., et al. Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors upregulates Akt and prevents apoptosis. J Biol. Chem. 279:2003;10962-10972